Login / Signup
Evolution: IMiDs to PPMs, revolution in DLBCL?
Grzegorz S Nowakowski
Published in:
Blood (2015)
In this issue of Blood, Hagner et al provide preclinical evidence that CC-122 might be active in both major molecular subtypes of diffuse large B-cell lymphoma (DLBCL).
Keyphrases
</>
diffuse large b cell lymphoma
epstein barr virus
cell therapy
single molecule
mesenchymal stem cells